Protagonist Therapeutics Market Sentiment

Protagonist Therapeutics Inc

PTGXNASDAQ

$142.80

1.831.3%

Dern. MÀJ: Sep 30, 11:35 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Protagonist Therapeutics Market Sentiment

Market sentiment signals for Protagonist Therapeutics (PTGX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 14.6% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

0.00

More calls — Bullish

16 calls · 0 puts

Avg Consensus PT

$129

-9.9%

Highest Price Target

$190

+33.1%

BMO Capital

Lowest Price Target

$38

-73.4%

Goldman Sachs

Short Interest

14.6%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 1, 2026	Barclays	Etzer Darout—	+26.1%	$153 → $180	Maintained	Overweight
Sep 1, 2026	BMO Capital	Etzer Darout—	+33.1%	$178 → $190	Maintained	Outperform
Aug 31, 2026	Citigroup	Geoff Meacham—	+27.5%	$175 → $182	Maintained	Buy
Aug 31, 2026	HC Wainwright & Co.	Douglas Tsao—	+19.0%	$167 → $170	Maintained	Buy
Aug 17, 2026	BMO Capital	Etzer Darout—	+24.6%	$112 → $178	Maintained	Outperform
Aug 10, 2026	Truist Securities	Srikripa Devarakonda—	+19.0%	$145 → $170	Maintained	Buy
Aug 10, 2026	Wedbush	Yun Zhong—	+21.1%	$118 → $173	Maintained	Outperform
Aug 10, 2026	Goldman Sachs	Richard Law—	+30.3%	$110 → $186	Upgrade	Neutral→Buy
Aug 6, 2026	Citigroup	Geoff Meacham—	+22.5%	$130 → $175	Maintained	Buy
Aug 6, 2026	Barclays	Etzer Darout—	+7.1%	$151 → $153	Maintained	Overweight
Jul 14, 2026	Barclays	Etzer Darout—	+5.7%	$119 → $151	Maintained	Overweight
Jul 7, 2026	Truist Securities	Srikripa Devarakonda—	+1.5%	$121 → $145	Maintained	Buy
May 10, 2026	Citigroup	Geoff Meacham—	-9.0%	$125 → $130	Maintained	Buy
May 6, 2026	Citizens	Jonathan Wolleben—	-4.1%	$120 → $137	Maintained	Market Outperform
May 6, 2026	Wedbush	Yun Zhong—	-17.4%	$112 → $118	Maintained	Outperform
Apr 15, 2026	Truist Securities	Srikripa Devarakonda—	-15.3%	$110 → $121	Maintained	Buy
Apr 7, 2026	Clear Street	Kaveri Pohlman—	-18.8%	$104 → $116	Maintained	Buy
Mar 19, 2026	Leerink Partners	Faisal Khurshid—	-23.0%	$107 → $110	Maintained	Outperform
Mar 19, 2026	JP Morgan	Brian Cheng—	-25.8%	$95 → $106	Maintained	Overweight
Mar 19, 2026	Citigroup	Geoff Meacham—	-12.5%	$115 → $125	Maintained	Buy
Mar 19, 2026	Barclays	Etzer Darout—	-16.7%	$113 → $119	Maintained	Overweight
Mar 3, 2026	Goldman Sachs	Richard Law—	-33.5%	$65 → $95	Maintained	Neutral
Feb 26, 2026	TD Cowen	Tara Bancroft—	-30.0%	$90 → $100	Maintained	Buy
Feb 26, 2026	Barclays	Etzer Darout—	-20.9%	$108 → $113	Maintained	Overweight
Feb 26, 2026	Citizens	Jonathan Wolleben—	-21.6%	$102 → $112	Maintained	Market Outperform